7523 — Art Vivant Co Balance Sheet
0.000.00%
- ¥15bn
- ¥22bn
- ¥11bn
- 62
- 67
- 75
- 81
Annual balance sheet for Art Vivant Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
C2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | — | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 3,544 | 3,986 | 5,480 | 4,773 | 5,753 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 13,819 | 14,519 | 15,391 | 15,797 | 15,847 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 23,027 | 25,166 | 27,943 | 29,481 | 29,681 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1,496 | 1,203 | 684 | 534 | 540 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 27,790 | 29,433 | 32,918 | 34,234 | 34,773 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 12,971 | 13,415 | 16,297 | 17,140 | 16,474 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 15,024 | 15,175 | 17,524 | 18,346 | 19,458 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 12,766 | 14,258 | 15,395 | 15,888 | 15,316 |
| Total Liabilities & Shareholders' Equity | 27,790 | 29,433 | 32,918 | 34,234 | 34,773 |
| Total Common Shares Outstanding |